DP-b99 in the Treatment of Acute High-risk Pancreatitis

Summary

Inflammation of the pancreas often leads to severe damage not only to the pancreas but also to other organs in the abdomen as well as to complications in organs further away like the lung and the kidney. This trial will examine if DP-b99, given to patients with non-severe inflammation of the pancreas, can mitigate the development of processes that can lead to serious complications of this disease.

Timeline

Start

2013-12

Primary completion

2015-05

Completion

2015-05

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment”

Drugs

Indications